menu

ReachMD

Be part of the knowledge.
Register

We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?

Register for free

Stroke Prevention in Patients with Atrial Fibrillation

close
ReachMD Healthcare Image
Restart
Resume
Read full article
Choose a format
Media formats available:
Details
Presenters
Comments
  • Overview

    Long-term anticoagulation is often viewed as inconvenient and somewhat risky, even for patients with atrial fibrillation who are at elevated risk for stroke. Are these factors overshadowing the evidence that demonstrates the effectiveness of anticoagulant therapy in preventing stroke? Dr. John Cairns, professor of medicine in the division of cardiology at the University of British Columbia in Canada, talks with host Dr. Doug Weaver about stroke prevention for patients with atrial fibrillation. Is it safe to stop anticoagulant therapy in this population, and if so, when should this decision be considered?

Facebook Comments

Recommended
Details
Presenters
Comments
  • Overview

    Long-term anticoagulation is often viewed as inconvenient and somewhat risky, even for patients with atrial fibrillation who are at elevated risk for stroke. Are these factors overshadowing the evidence that demonstrates the effectiveness of anticoagulant therapy in preventing stroke? Dr. John Cairns, professor of medicine in the division of cardiology at the University of British Columbia in Canada, talks with host Dr. Doug Weaver about stroke prevention for patients with atrial fibrillation. Is it safe to stop anticoagulant therapy in this population, and if so, when should this decision be considered?

Facebook Comments

Schedule16 Oct 2021